Competitor Analysis: HIV Small Molecule Therapeutics

La Merie Publishing
December 1, 2011
100 Pages - SKU: LAM3790119
The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides a competitor evaluation in the field of marketed products and R&D projects of HIV small molecule therapeutics as of December 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of marketed products and currently active projects in research and development of HIV Small Molecule Therapeutics. In addition, the report lists company-specific product portfolios and R&D pipelines of HIV Small Molecule Therapeutics. Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.


Additional Information

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

More Drug Discovery reports by La Merie Publishing

Competitor Analysis: Alpha Synuclein and LRRK2 Inhibitors - Novel Drug Candidates for Parkinson’s Disease by La Merie Publishing
Competitor Analysis: Alpha Synuclein and LRRK2 Inhibitors - Novel Drug Candidates for Parkinson’s Disease The Competitive Intelligence report about Alpha Synuclein and LRRK2 ...
Competitor Analysis: Nonalcoholic Steatohepatitis (NASH) – Novel Drug Candidates by La Merie Publishing
Competitor Analysis: Nonalcoholic Steatohepatitis (NASH) – Novel Drug Candidates The Competitive Intelligence report about Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates provides ...
Competitor Analysis: Cancer Peptides by La Merie Publishing
Competitor Analysis: Cancer Peptides The Competitive Intelligence Report Cancer Peptides as of November 2014 provides a competitor analysis in the product portfolios and development pipeline ...
Competitor Analysis: Cardiometabolic Peptides by La Merie Publishing
Competitor Analysis: Cardiometabolic Peptides The Competitive Intelligence Report Cardiometabolic Peptides as of November 2014 provides a competitor analysis in ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 642  
    Global Site License  USD 1,926  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!